LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 38.51 | 17.25 | 15 | 2906 | 0.0052 | -0.0187 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 38.51 | 17.25 | 1078 | 2906 | 0.3710 | 0.7490 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 40.48 | 17.25 | 1 | 3125 | 0.0003 | -0.3159 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 40.48 | 17.25 | 986 | 3125 | 0.3154 | 0.7149 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 40.48 | 17.25 | 16 | 3125 | 0.0051 | -0.0100 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 40.48 | 17.25 | 1132 | 3125 | 0.3622 | 0.7467 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 42.45 | 17.25 | 1 | 3504 | 0.0003 | -0.3103 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 42.45 | 17.25 | 1020 | 3504 | 0.2911 | 0.7026 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 42.45 | 17.25 | 15 | 3504 | 0.0043 | -0.0181 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 42.45 | 17.25 | 1172 | 3504 | 0.3345 | 0.7337 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 44.42 | 17.25 | 1 | 3895 | 0.0003 | -0.3053 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 44.42 | 17.25 | 1061 | 3895 | 0.2724 | 0.6935 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 44.42 | 17.25 | 13 | 3895 | 0.0033 | -0.0355 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 44.42 | 17.25 | 1214 | 3895 | 0.3116 | 0.7229 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 46.39 | 17.25 | 1 | 4141 | 0.0002 | -0.3024 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 46.39 | 17.25 | 1114 | 4141 | 0.2690 | 0.6940 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 46.39 | 17.25 | 9 | 4141 | 0.0022 | -0.0790 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 46.39 | 17.25 | 1250 | 4141 | 0.3018 | 0.7188 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 48.36 | 17.25 | 1 | 4390 | 0.0002 | -0.2998 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 48.36 | 17.25 | 1159 | 4390 | 0.2640 | 0.6930 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 48.36 | 17.25 | 12 | 4390 | 0.0027 | -0.0444 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 48.36 | 17.25 | 1308 | 4390 | 0.2979 | 0.7188 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 50.33 | 17.25 | 1 | 4651 | 0.0002 | -0.2972 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 50.33 | 17.25 | 1214 | 4651 | 0.2610 | 0.6935 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 50.33 | 17.25 | 14 | 4651 | 0.0030 | -0.0255 | MN20160310_N02 | E18 |